CFTR and lung adenocarcinoma: Our finding that CFTR is directly involved in lung adenocarcinoma progression receives further support from a recent large Danish register study in which morbidity and mortality of 108,035 individuals genotyped for the CFTR reduced function variant p.Phe508del was analyzed during up to 15 years of follow-up (Çolak et al. 2020).